Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
Kobinger, Gary P
6 records totalling $8,347,914.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| Canadian Institutes of Health Research | $8,347,914 | 6 records |
Records
Kobinger, Gary P
$3,997,503.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2017-2018
Canada
Kobinger, Gary P
$1,402,860.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2016-2017
Canada
Development of an animal model, a protective vaccine and monoclonal antibodies against Crimean-Congo Hemorrhagic Fever Virus
Kobinger, Gary P
$1,400,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2016-2017
Canada
Canada Research Chair Tier 1
Kobinger, Gary P
$999,356.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2019-2020
Canada
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to: • Contribute to the global response to the 2019-nCoV outbreak; • Enhance local, national and/or internat...
KOBINGER, Gary P
$318,945.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2011-2012
Canada
A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study
Kobinger, Gary P
$229,250.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2015-2016
Canada
Determinants of virulence and transmission in the West African Ebola outbreak